[ Price : $8.95]
FDA issues a revised final guidance entitled Investigational COVID-19 Convalescent Plasma.[ Price : $8.95]
FDA announces a 3/23 virtual public workshop entitled Roadmap to 2030 for New Drug Evaluation in Older Adults.[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection revision entitled Application for FDA Approval To Market a New...[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Alnylam Pharmaceuticals in response to its rare pediatric disease...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Medical Devices; Device Tracking 21 CFR Pa...[ Price : $8.95]
FDA tells Mallinckrodt that pandemic-related travel restrictions make it necessary to defer action pending a site inspection for i...[ Price : $8.95]
FDA grants BrainQs artificial intelligence-powered technology for ischemic strokes a breakthrough device designation.[ Price : $8.95]
A provision in a budget reconciliation bill moving its way through the U.S. House of Representatives provides FDA with a $500 mill...